Cholesterol ester-reducing amides of hexahydroindolinols

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

542429, A61K 3140, C07D20904

Patent

active

041940024

ABSTRACT:
Long chain fatty acid amides of styryl hexahydroindolinols in which the amido portions have ethyleneically unsaturated positions or cyclopropanyl rings, eg 1-(1-oxo-9-cis-octadecenyl)-(3aRS, 4RS, 7aRS)-4-(Z)-(3,4-dimethoxy)-styryl-hexahydro-4-indolinol, are useful as cholesterol ester-reducing agents and are obtainable by reacting corresponding long chain carboxylic acids (or derivatives thereof) with appropriate 4-styryl-4-hexahydroindolinols.

REFERENCES:
patent: 3551462 (1970-12-01), Seki et al.
patent: 3621043 (1971-11-01), Seki et al.
patent: 3728459 (1973-04-01), Seki et al.
patent: 3741999 (1973-06-01), Seki et al.
patent: 3995059 (1976-11-01), Fukumaru et al.
patent: 4129658 (1978-12-01), Berthold

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cholesterol ester-reducing amides of hexahydroindolinols does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cholesterol ester-reducing amides of hexahydroindolinols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol ester-reducing amides of hexahydroindolinols will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1124268

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.